Bausch + Lomb Deal History & Licensing Activity
Bausch + Lomb is a large pharma headquartered in CA. Over the past three years, Bausch + Lomb has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (1 deal). The company currently has 19 active clinical trials, primarily in Ophthalmology.
Deals (12mo)
1
Active Trials
19
Top Modality
Small Molecules
Focus Area
Ophthalmology
Bausch + Lomb Pipeline Focus
Therapeutic areas and modalities where Bausch + Lomb is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Bausch + Lomb Strategic Signals
Key indicators of Bausch + Lomb's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Bausch + Lomb Clinical Pipeline
Bausch + Lomb has 19 active clinical trials across 5 development phases.
4
Unknown
9
Not Applicable
2
Phase 4
1
Phase 1
3
Phase 2
See How Your Asset Matches Bausch + Lomb's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Ophthalmology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Ophthalmology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for ophthalmology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Bausch + Lomb Licensing & Deal Activity
Bausch + Lomb is a large pharma company based in CA that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Bausch + Lomb ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Bausch + Lomb include Ophthalmology (1 deal and trial). In terms of modality, Bausch + Lomb has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Bausch + Lomb and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Bausch + Lomb's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.